Grantham, Mayo, Van Otterloo & Co (GMO)’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-9,727
Closed -$778K – 736
2022
Q2
$778K Buy
9,727
+1,100
+13% +$111K ﹤0.01% 550
2022
Q1
$976K Sell
8,627
-500
-5% -$56.1K ﹤0.01% 531
2021
Q4
$1.04M Sell
9,127
-712
-7% -$76.5K 0.01% 533
2021
Q3
$1.14M Buy
9,839
+807
+9% +$101K 0.01% 517
2021
Q2
$1.09M Sell
9,032
-80
-0.9% -$9.47K 0.01% 526
2021
Q1
$982K Buy
+9,112
New +$1.01M 0.01% 599
2019
Q4
– Sell
-272,029
Closed -$15.5M – 708
2019
Q3
$15.5M Sell
272,029
-247,213
-48% -$14.4M 0.11% 134
2019
Q2
$29.2M Buy
+519,242
New +$26.9M 0.21% 79

Other funds holding DVA

Grantham, Mayo, Van Otterloo & Co (GMO)'s DVA Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of DaVita (DVA) in Q3 2022, closing a stake of 9,727 shares — an estimated $778K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DVA in Q2 2019 and held it in 8 quarters. The position peaked at $29.2M in Q2 2019. 441 funds tracked by Wall St. Rank hold DVA as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining DaVita position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,727 DaVita shares in Q3 2022, an estimated $778K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DaVita in Q2 2019 and held it in 8 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s DaVita position peaked at $29.2M in Q2 2019.
  • 441 funds tracked by Wall St. Rank held DaVita as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.